Heat shock factor 1 inhibition sensitizes pancreatic cancer to gemcitabine via the suppression of cancer stem cell-like properties.

Qin T, Chen K, Li J, Qian W, Xiao Y, Wu E, Ma J, Chen Z, Wang Z, Ma Q, et al. Heat shock factor 1 inhibition sensitizes pancreatic cancer to gemcitabine via the suppression of cancer stem cell-like properties. Biomed Pharmacother. 2022;148:112713.